脂蛋白A与中老年肥胖患者颈部动脉粥样硬化斑块的相关性分析
Correlation between Lipoprotein A and Carotid Atherosclerotic Plaque in Middle-Aged and Elderly Obese Patients
DOI: 10.12677/ACM.2023.132331, PDF,   
作者: 唐思思*, 邓志莹, 郭宗君#:青岛大学附属医院老年医学科,山东 青岛
关键词: 脂蛋白A肥胖动脉粥样硬化斑块Lipoprotein(a) Obesity Atherosclerosis Plaque
摘要: 目的:探讨脂蛋白A与中老年肥胖患者颈部动脉粥样硬化斑块的相关性。方法:选取青岛市某三甲医院中老年肥胖患者100例纳入观察组,根据颈部血管彩超检查结果,将其分为斑块组(49例)和无斑块组(51例),再根据颈动脉内斑块回声性质,将斑块组分为稳定斑块亚组(26例)和不稳定斑块亚组(23例)。另选取60例体检健康者作为对照组,取空腹静脉血测定脂蛋白A,比较各组脂蛋白A水平。结果:观察组的脂蛋白A水平高于对照组,差异有统计学意义(P < 0.05)。与无斑块组相比,斑块组的年龄、LP(a)、SBP、TC、TG、LDL-C、FBG水平明显升高,差异均有统计学意义(P < 0.05)。不稳定斑块亚组LP(a)、TC、LDL-C水平高于稳定斑块亚组,差异有统计学意义(P = 0.001, P = 0.027, P = 0.032)。Logistic回归分析显示LP(a)是影响颈动脉粥样硬化斑块的稳定性的危险因素(P < 0.05)。Spearson法分析显示LP(a)水平与IMT检测值呈正相关(P < 0.001)。结论:中老年肥胖患者LP(a)水平呈高表达,其可能与颈动脉粥样硬化发生有关。
Abstract: Objective: To investigate the correlation between lipoprotein A and atherosclerotic plaque in the neck of middle-aged and elderly obese patients. Methods: A total of 100 middle-aged and elderly obese patients from a third-class A hospital in Qingdao were included in the observation group. Ac-cording to the results of cervical vascular color Doppler ultrasound, they were divided into plaque group (49 cases) and no plaque group (51 cases). According to the echo properties of carotid plaques, the plaque group was divided into stable plaque subgroup (26 cases) and unstable plaque subgroup (23 cases). Another 60 healthy subjects were selected as the control group. Fasting ve-nous blood was taken to determine the level of lipoprotein A. Results: The level of lipoprotein A in observation group was higher than that in control group, and the difference was statistically signif-icant (P < 0.05). Compared with the non-plaque group, the levels of age, LP(a), SBP, TC, TG, LDL-C and FBG in the plaque group were significantly increased, with statistical significance (P < 0.05). The levels of LP(a), TC and LDL-C in the unstable plaque subgroup were higher than those in the stable plaque subgroup, and the difference was statistically significant (P = 0.001, P = 0.027, P = 0.032). Logistic regression analysis showed that LP(a) was a risk factor affecting the stability of carotid ath-erosclerotic plaque (P < 0.05). Spearson analysis showed that LP(a) level was positively correlated with IMT (P < 0.001). Conclusion: LP(a) level is highly expressed in middle-aged and elderly obese patients, which may be related to the occurrence of carotid atherosclerosis.
文章引用:唐思思, 邓志莹, 郭宗君. 脂蛋白A与中老年肥胖患者颈部动脉粥样硬化斑块的相关性分析[J]. 临床医学进展, 2023, 13(2): 2362-2368. https://doi.org/10.12677/ACM.2023.132331

参考文献

[1] Elagizi, A., Kachur, S., Carbone, S., Lavie, C. and Blair, S.N. (2020) A Review of Obesity, Physical Activity, and Car-diovascular Disease. Current Obesity Reports, 9, 571-581. [Google Scholar] [CrossRef] [PubMed]
[2] Rohm, T.V., Meier, D.T., Olefsky, J.M. and Donath, M.Y. (2022) Inflammation in Obesity, Diabetes, and Related Disorders. Immunity, 55, 31-55. [Google Scholar] [CrossRef] [PubMed]
[3] Chrysant, S.G. (2019) Pathophysiology and Treatment of Obesity-Related Hypertension. The Journal of Clinical Hypertension, 21, 555-559. [Google Scholar] [CrossRef] [PubMed]
[4] Aboonabi, A., Meyer, R.R. and Singh, I. (2019) The Association between Metabolic Syndrome Components and the Development of Atherosclerosis. Journal of Human Hypertension, 33, 844-855. [Google Scholar] [CrossRef] [PubMed]
[5] Geeraerts, X., Bolli, E., Fendt, S.M. and Van Ginderachter, J.A. (2017) Macrophage Metabolism as Therapeutic Target for Cancer, Atherosclerosis, and Obesity. Frontiers in Immunol-ogy, 8, Article 289. [Google Scholar] [CrossRef] [PubMed]
[6] Nagarajan, S.R., Cross, E., Sanna, F. and Hodson, L. (2022) Dysregulation of Hepatic Metabolism with Obesity: Factors Influencing Glucose and Lipid Metabolism. Proceedings of the Nutrition Society, 81, 1-11. [Google Scholar] [CrossRef
[7] Goncalves, I., Sun, J., Tengryd, C., et al. (2021) Plaque Vul-nerability Index Predicts Cardiovascular Events: A Histological Study of an Endarterectomy Cohort. Journal of the American Heart Association, 10, e021038. [Google Scholar] [CrossRef
[8] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要[J]. 心脑血管病防治, 2022, 22(4): 20-36+40.
[9] Rehberger Likozar, A., Zavrtanik, M. and Šebeštjen, M. (2020) Lipoprotein(a) in Atherosclerosis: From Pathophysiology to Clinical Relevance and Treatment Options. An-nals of Medicine, 52, 162-177. [Google Scholar] [CrossRef] [PubMed]
[10] 中国营养学会肥胖防控分会, 中国营养学会临床营养分会, 中华预防医学会行为健康分会, 中华预防医学会体育运动与健康分会. 中国居民肥胖防治专家共识[J]. 中国预防医学杂志, 2022, 23(5): 321-339.
[11] 魏亚琳. 颈动脉硬化影响因素的决策树模型研究[D]: [硕士学位论文]. 青岛: 青岛大学, 2021.
[12] Maranhão, R.C., Carvalho, P.O., Strunz, C.C. and Pileggi, F. (2014) Lipoprotein(a): Structure, Pathophysiology and Clinical Implications. Arquivos Brasileiros de Cardiologia, 103, 76-84. [Google Scholar] [CrossRef] [PubMed]
[13] Rawther, T. and Tabet, F. (2019) Biology, Pathophysiology and Current Therapies That Affect Lipoprotein (a) Levels. Journal of Molecular and Cellular Cardiology, 131, 1-11. [Google Scholar] [CrossRef] [PubMed]
[14] Allen, S., Khan, S., Tam, S., Koschinsky, M., Taylor, P. and Yacoub, M. (1998) Expression of Adhesion Molecules by Lp(a): A Potential Novel Mechanism for Its Atherogenicity. The FASEB Journal, 12, 1765-1776. [Google Scholar] [CrossRef] [PubMed]
[15] Argraves, K.M., Kozarsky, K.F., Fallon, J.T., Harpel, P.C. and Strickland, D.K. (1997) The Atherogenic Lipoprotein Lp(a) Is Internalized and Degraded in a Process Mediated by the VLDL Receptor. Journal of Clinical Investigation, 100, 2170-2181. [Google Scholar] [CrossRef
[16] Wu, H.D., et al. (2004) High Lipoprotein(a) Levels and Small Apolipoprotein(a) Sizes Are Associated with Endothelial Dys-function in a Multiethnic Cohort. Journal of the American College of Cardiology, 43, 1828-1833. [Google Scholar] [CrossRef] [PubMed]
[17] Scipione, C.A., et al. (2015) Mechanistic Insights into Lp(a)-Induced IL-8 Expression: A Role for Oxidized Phospholipid Modification of Apo(a). Journal of Lipid Research, 56, 2273-2285. [Google Scholar] [CrossRef
[18] Dangas, G., et al. (1998) Lipoprotein(a) and Inflamma-tion in Human Coronary Atheroma: Association with the Severity of Clinical Presentation. Journal of the American Col-lege of Cardiology, 32, 2035-2042. [Google Scholar] [CrossRef
[19] 徐东进. 同型半胱氨酸、脂蛋白a及载脂蛋白AI/载脂蛋白B水平与缺血性脑卒中患者凝血指标相关性的探讨[J]. 吉林医学, 2023, 44(1): 68-71.
[20] 任云霞, 王斌, 吕淑萍, 程晋芳, 高宇平. 冠心病病人脂蛋白a与冠状动脉病变的相关性[J]. 中西医结合心脑血管病杂志, 2021, 19(22): 3963-3965+3971.